Try our Advanced Search for more refined results
IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Lieff Cabraser
- Sarraf Gentile
- K&L Gates
- Foley & Lardner
- Andrus Anderson
- Baker Botts
- Kirkland & Ellis
- McCune Law
- Patterson Belknap
- Fiddler Gonzalez
- Ahern and Associates
- Spiro Harrison
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Burns Charest
- Gustafson Gluek
- Armstrong Teasdale
- Levin Sedran
- Kohn Swift
- Cleary Gottlieb
- Tostrud Law Group
- Wilson Sonsini
- Skadden Arps
- Gross & Belsky
- Tycko & Zavareei
- Freedman Boyd
- Girard Sharp
- Steyer Lowenthal
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Krantz & Berman
- Lockridge Grindal
- Rosenn Jenkins
- Barrack Rodos
- Obermayer Rebmann
- Schneider Wallace
- Cole Schotz
- Anselmi & Carvelli
- Saiber LLC
- Cuneo Gilbert
- Stradley Ronon
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- Motley Rice
- Pendley Baudin
- Zwerling Schachter
- Rule Garza
- Earp Cohn
- Hogan Lovells
- Joseph Saveri Law Firm
- Competition Law Partners
- Seeger Weiss
- King & Spalding
- WilmerHale
- Larson King
- Barrett Law Group
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Polsinelli PC
- Neufeld Scheck
- Spector Roseman
- Robbins Geller
- Neal & Harwell
- Norton Rose
- Goldman Scarlato
- Heins Mills
- Hunt Ortmann
- Hach Rose Schirripa
- Edelson Lechtzin
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Shinder Cantor
- Wexler Boley
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Stevens & Lee
- Zuckerman Spaeder
- Williams & Connolly
- Lyden Chappell
- Barnes & Thornburg
- Segal McCambridge
- Grabar Law
- Calcaterra Pollack
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Reed Smith
- Napoli Shkolnik
- DiCello Levitt
- Carella Byrne
- NastLaw
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Faegre Drinker
- Bailey Duquette
- Sills Cummis
- Ballard Spahr
- Cozen O'Connor
- Morrison & Foerster
- Debevoise & Plimpton
- Blank Rome
- Goodwin Procter
- DLA Piper
- Francis Mailman
- O'Melveny & Myers
- Nussbaum Law Group
- Bailey & Glasser
- Venable LLP
- Kaplan Fox
- Steptoe LLP
- Marks O'Neill
- Dugan Law Firm
- Shapiro Arato
- Scott&Scott
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Dilworth Paxson
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- White and Williams
- Morgan Lewis
- Wolf Haldenstein
- Tarter Krinsky
- Cotchett Pitre
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Winston & Strawn
- Baker & Hostetler
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Boies Schiller
- Crowell & Moring
- Radice Law Firm
- Whatley Kallas
- Weil Gotshal
- Cohen Milstein
- Proskauer Rose
- Freshfields
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Haynes Boone
- Miller Shah
- McDermott Will & Emery
- Duane Morris
- Zimmerman Reed
- Troutman
- Lowenstein Sandler
- Lewis Brisbois
- Berger Montague
- Fox Rothschild
- Glancy Prongay
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Linklaters LLP
- Arnold & Porter
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Perrigo Co. PLC
- Impax Laboratories, Inc.
- Sandoz International GmbH
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Endo International PLC
- Bausch Health Cos. Inc.
- Cencora Inc.
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Glenmark Pharmaceuticals Ltd.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- Humana Inc.
- The Cigna Group
- Viatris Inc.
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- McKesson Corp.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
February 20, 2025
Drug Buyers Get OK On $275M Sandoz Antitrust Settlement
Swiss drugmaker Sandoz and its subsidiaries will pay consumers, insurers and other "end payer plaintiffs" $275 million to settle class action claims that it conspired with other companies to fix the price of certain generic drugs, under a deal that got preliminary approval from a Pennsylvania federal court Wednesday.
-
February 04, 2025
McKesson, Others Beat Indirect Drug Reseller Price-Fix Suit
A Pennsylvania federal judge permanently tossed antitrust claims from indirect generic-drug resellers who alleged distributors like McKesson Corp. and AmerisourceBergen colluded with manufacturers to fix prices of many medications, writing Monday the plaintiffs fail to show the existence of such an agreement between drugmakers and distributors.
-
December 17, 2024
Sandoz Cuts $275M Deal For More Price-Fixing Claims
Swiss drugmaker Sandoz said Tuesday it has reached a $275 million settlement to end claims from consumers, insurers and others in the sprawling multidistrict litigation over alleged price-fixing in the generic-drug industry.
-
October 16, 2024
Direct Buyers Get Final OK For $44M Drug Price-Fixing Deal
A Pennsylvania federal court has granted final approval to $44.4 million in settlements between drugmakers Apotex, Breckenridge and Heritage and direct purchasers in a multidistrict litigation over alleged price-fixing in the generic-drug industry.
-
September 24, 2024
Buyers Seek $97M Fees From $335M Drug Price-Fixing Deals
A class of direct purchaser plaintiffs in the multidistrict antitrust litigation over generic drug pricing asked a Pennsylvania federal judge Monday to award them $97 million in fees across six settlements with pharmaceutical firms, arguing its attorneys "spent the better part of a decade and hundreds of thousands of hours litigating this case."
-
June 27, 2024
Judge OKs $10M Deal In Generic Price-Fixing MDL
Heritage Pharmaceuticals has secured a Pennsylvania federal court's blessing on the second $10 million deal it has inked this year in hopes of extricating itself from multidistrict litigation accusing the generic-drug maker of working with others to hike up the cost of off-brand drugs.
-
May 16, 2024
$5.5M Apotex Generic Drug Price-Fixing Deal Gets Initial OK
A Pennsylvania federal judge gave preliminary approval to yet another settlement in the sweeping generic drug price-fixing multidistrict litigation, this time signing off on pharmaceutical company Apotex's $5.5 million settlement with clinics, hospitals and independent pharmacies.
-
April 02, 2024
Healthcare In Court: Idaho AG Not 'Cute' On Abortion Ban
Idaho's solicitor general had a hard day at the Ninth Circuit, where a panel tried and failed to get a lock on the state attorney general's stance on Idaho's abortion ban. Home Depot pressed the U.S. Supreme Court to review a $2.67 billion settlement in antitrust litigation against the Blue Cross Blue Shield Association. And in Texas, a woman charged with murder for inducing her own abortion sued the prosecutors behind the case.
-
March 27, 2024
NY AG, Others Blast Sandoz Deal 'Tax' On Future Settlements
New York's attorney general was one of three objectors Tuesday to a provision in Sandoz's proposed $265 million settlement with a class of drug wholesalers in Pennsylvania federal court that they say will delay any future generic-drug price-fixing litigation deals by taxing agreements over $119.25 million.
-
March 14, 2024
Drug Wholesalers Want Preliminary OK On $265M Sandoz Deal
A group of direct purchasers of generic drugs has asked a Pennsylvania federal court for approval of a $265 million settlement with Swiss drugmaker Sandoz over allegations of federal antitrust violations.